Management of Acute Left Vertebral Artery Occlusion
For acute left vertebral artery occlusion causing symptomatic posterior circulation ischemia, initiate antiplatelet therapy immediately with aspirin 81-325 mg daily, aspirin plus extended-release dipyridamole (25/200 mg twice daily), or clopidogrel 75 mg daily, and consider anticoagulation for at least 3 months if there is angiographic evidence of thrombus. 1, 2, 3
Acute Phase Management
Initial Diagnostic Workup
- Obtain MRA or CTA (not ultrasound) to evaluate the vertebral arteries and define the location and severity of occlusion 1, 2, 4
- If noninvasive imaging fails to adequately define the pathoanatomy and the patient is a revascularization candidate, proceed to catheter-based contrast angiography 1, 2
- Assess for posterior circulation symptoms: dizziness, vertigo, diplopia, perioral numbness, blurred vision, tinnitus, ataxia, bilateral sensory deficits, or syncope 4
Acute Intervention Considerations
For patients presenting with acute vertebrobasilar occlusion:
If basilar artery is occluded (not just vertebral artery alone) with NIHSS ≥6 and PC-ASPECTS ≥6:
For isolated vertebral artery occlusion: Intravenous thrombolytic therapy has shown variable outcomes; the decision depends on timing and clinical presentation 3
Medical Therapy (Class I Recommendations)
Antiplatelet therapy - Choose one of the following 1, 2, 3:
- Aspirin 81-325 mg daily, OR
- Aspirin 25 mg + extended-release dipyridamole 200 mg twice daily, OR
- Clopidogrel 75 mg daily
Anticoagulation - When angiographic evidence of thrombus is present at the origin or extracranial portion of the vertebral artery 3:
- Heparin (dose-adjusted to PTT 1.5-2.0 times control) followed by warfarin (INR 2.0-3.0), OR
- Low molecular weight heparin followed by warfarin, OR
- Direct oral anticoagulation
- Duration: minimum 3 months, then transition to antiplatelet therapy 3
The WASID trial demonstrated that aspirin and warfarin are equally efficacious for noncardioembolic posterior circulation stroke, so either approach is acceptable 3
Risk Factor Modification (Class I)
Aggressive atherosclerotic risk reduction following the same standards as for carotid atherosclerosis 1, 2:
- Statin therapy for lipid management
- Blood pressure control
- Diabetes management
- Smoking cessation
- Lifestyle modifications
Subacute and Chronic Management
Surveillance Imaging
- Perform serial noninvasive imaging (CTA or MRA) to assess disease progression and detect new lesions 1, 2, 3
- Imaging intervals should be similar to those used for carotid revascularization monitoring 1, 2
Revascularization Considerations
Revascularization is rarely indicated for isolated vertebral artery occlusion because:
- When both vertebral arteries are patent and one has significant stenosis/occlusion, the contralateral vertebral artery usually provides sufficient basilar artery flow (assuming anatomic continuity) 3
- Surgical options (endarterectomy, vessel reconstruction) carry perioperative mortality rates of 0-8% and complication rates of 2.5-55% depending on location 3
- No randomized trials support surgical or endovascular intervention for vertebral artery disease 4, 3
Critical Pitfalls to Avoid
Cerebellar infarction monitoring: Approximately 25% of patients with cerebellar stroke develop mass effect causing rapid deterioration, and 20% develop hydrocephalus 6. Monitor closely during the first week (mass effect peaks on day 3) for:
- Signs of brainstem compression
- Hydrocephalus from aqueductal obstruction
- Fluctuating neurological examination
If clinical deterioration occurs, consider urgent suboccipital decompressive craniectomy rather than external ventricular drain alone, as EVD carries risk of upward herniation 6
Avoid revascularization in asymptomatic patients with vertebral artery stenosis/occlusion unless specific criteria are met (e.g., ipsilateral internal mammary artery needed for CABG) 1, 2
Alternative antiplatelet agents if aspirin is contraindicated: clopidogrel 75 mg daily or ticlopidine 250 mg twice daily 4, 3